Santica Marcovina Selected Research

Santica Marcovina Research Topics

Disease

23	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2024 - 09/2006
20	Type 2 Diabetes Mellitus (MODY) 01/2022 - 09/2006
18	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 03/2005
10	Insulin Resistance 01/2021 - 05/2005
7	Dyslipidemias (Dyslipidemia) 11/2023 - 09/2006
7	Obesity 09/2023 - 05/2005
7	Inflammation (Inflammations) 01/2018 - 05/2005
6	Glucose Intolerance 01/2021 - 04/2005
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 07/2003
5	Coronary Disease (Coronary Heart Disease) 01/2022 - 12/2009
4	Weight Loss (Weight Reduction) 01/2021 - 04/2005
4	Hypertension (High Blood Pressure) 01/2018 - 04/2005
4	Atherosclerosis 08/2017 - 01/2002
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2010 - 04/2005
3	Diabetes Complications 04/2024 - 01/2022
3	Overweight 09/2023 - 01/2018
3	Cognitive Dysfunction 03/2014 - 08/2011
3	Diabetes Mellitus 04/2011 - 02/2007
2	Ischemic Stroke 01/2022 - 05/2010
2	Carotid Artery Diseases 06/2014 - 01/2011
2	Hyperlipidemias (Hyperlipidemia) 07/2010 - 04/2005
1	Maple Syrup Urine Disease 04/2024
1	Noncommunicable Diseases 04/2024
1	Disease Progression 11/2022
1	Heart Failure 01/2022
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Hypoglycemia (Reactive Hypoglycemia) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Chronic Disease (Chronic Diseases) 12/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2017
1	Myocardial Infarction 01/2017
1	Albuminuria 06/2016
1	Gestational Diabetes (Gestational Diabetes Mellitus) 07/2014

Drug/Important Bio-Agent (IBA)

18	LipidsIBA 11/2023 - 09/2006
11	Lipoprotein(a)IBA 01/2023 - 01/2002
11	Triglycerides (Triacylglycerol)IBA 11/2021 - 04/2005
9	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 04/2005
9	HDL CholesterolIBA 04/2017 - 04/2005
7	oxidized low density lipoproteinIBA 11/2021 - 09/2006
7	LDL CholesterolIBA 01/2020 - 12/2007
7	Metformin (Glucophage)FDA LinkGeneric 12/2018 - 04/2005
6	Insulin (Novolin)FDA Link 01/2018 - 05/2005
6	CholesterolIBA 08/2017 - 04/2005
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2011
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2007
5	C-PeptideIBA 01/2021 - 06/2007
5	Lipoproteins (Lipoprotein)IBA 07/2014 - 03/2007
4	Hemoglobins (Hemoglobin)IBA 04/2024 - 03/2014
4	ApolipoproteinsIBA 04/2011 - 01/2006
4	HDL LipoproteinsIBA 04/2011 - 07/2008
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2024 - 01/2013
3	AlbuminsIBA 01/2020 - 06/2016
3	Apoprotein(a) (Apolipoprotein (a))IBA 01/2017 - 05/2010
3	AdiponectinIBA 05/2016 - 01/2012
2	AutoantibodiesIBA 11/2022 - 09/2010
2	Glucagon (Glukagon)FDA Link 01/2021 - 01/2021
2	ProinsulinIBA 01/2019 - 01/2019
2	C-Reactive ProteinIBA 01/2018 - 05/2005
2	Cystatin CIBA 08/2017 - 08/2011
2	Protein Isoforms (Isoforms)IBA 01/2017 - 05/2010
2	AdipokinesIBA 07/2014 - 04/2011
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2014 - 09/2008
2	Apolipoproteins AIBA 02/2012 - 05/2010
2	LDL Lipoproteins (beta Lipoproteins)IBA 04/2011 - 12/2009
2	Hemoglobin AIBA 11/2009 - 02/2007
2	Niacin (Nicotinic Acid)FDA LinkGeneric 09/2008 - 12/2007
1	trans-crotonin (CTN)IBA 04/2024
1	Advanced Glycation End ProductsIBA 04/2024
1	OsteocalcinIBA 04/2024
1	Hydroxyproline (4 Hydroxyproline)IBA 04/2024
1	pyridinolineIBA 04/2024
1	deoxypyridinolineIBA 04/2024
1	methyl butyrateIBA 04/2024
1	Amino Acids FDA Link 04/2024
1	Alkaline PhosphataseIBA 04/2024
1	Troponin T (Troponin T1)IBA 04/2024
1	Insulin-Like PeptidesIBA 04/2024
1	Parathyroid Hormone (Parathormone)IBA 04/2024
1	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2024
1	ProcollagenIBA 04/2024
1	Troponin IIBA 04/2024
1	Growth Hormone (Somatotropin)IBA 04/2024
1	TroponinIBA 04/2024
1	pro-brain natriuretic peptide (1-76)IBA 04/2024
1	Uric Acid (Urate)IBA 09/2023
1	amsonic acid (DAS)IBA 11/2022
1	ProdigyIBA 11/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	CreatinineIBA 01/2020
1	NAD (NADH)IBA 01/2017
1	ORALIT (ORS)IBA 01/2017
1	LeptinIBA 07/2014
1	Nonesterified Fatty Acids (NEFA)IBA 07/2014
1	HDL3 LipoproteinsIBA 06/2014
1	palmitoleic acidIBA 06/2014

Therapy/Procedure

11	Glycemic Control 01/2022 - 02/2007
9	Therapeutics 01/2018 - 04/2005
2	Blood Component Removal (Apheresis) 02/2012 - 04/2009
1	Caloric Restriction 01/2022